In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles CA Simpson, KJ Salleng, DE Cliffel, DL Feldheim Nanomedicine: Nanotechnology, Biology and Medicine 9 (2), 257-263, 2013 | 230 | 2013 |
Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell counts CA Simpson, AC Agrawal, A Balinski, KM Harkness, DE Cliffel ACS nano 5 (5), 3577-3584, 2011 | 111 | 2011 |
Nanoscale structure–activity relationships, mode of action, and biocompatibility of gold nanoparticle antibiotics J Bresee, CM Bond, RJ Worthington, CA Smith, JC Gifford, CA Simpson, ... Journal of the American Chemical Society 136 (14), 5295-5300, 2014 | 86 | 2014 |
Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions CA Simpson, BJ Huffman, AE Gerdon, DE Cliffel Chemical research in toxicology 23 (10), 1608-1616, 2010 | 82 | 2010 |
Gold nanoparticles to improve HIV drug delivery C Garrido, CA Simpson, NP Dahl, J Bresee, DC Whitehead, EA Lindsey, ... Future medicinal chemistry 7 (9), 1097-1107, 2015 | 77 | 2015 |
Tiopronin gold nanoparticle precursor forms aurophilic ring tetramer CA Simpson, CL Farrow, P Tian, SJL Billinge, BJ Huffman, KM Harkness, ... Inorganic chemistry 49 (23), 10858-10866, 2010 | 54 | 2010 |
A structural mass spectrometry strategy for the relative quantitation of ligands on mixed monolayer-protected gold nanoparticles KM Harkness, BC Hixson, LS Fenn, BN Turner, AC Rape, CA Simpson, ... Analytical chemistry 82 (22), 9268-9274, 2010 | 50 | 2010 |
Development of a SARS-CoV-2 vaccine candidate using plant-based manufacturing and a tobacco mosaic virus-like nano-particle JM Royal, CA Simpson, AA McCormick, A Phillips, S Hume, J Morton, ... Vaccines 9 (11), 1347, 2021 | 48 | 2021 |
Gastrointestinal bioavailability of 2.0 nm diameter gold nanoparticles CA Smith, CA Simpson, G Kim, CJ Carter, DL Feldheim Acs Nano 7 (5), 3991-3996, 2013 | 43 | 2013 |
Energy and nitrogen metabolism of red deer (Cervus elaphus) in cold environments; a comparison with cattle and sheep. AM Simpson, AJF Webster, JS Smith, CA Simpson | 33 | 1978 |
The efficiency of utilization of dietary energy for growth in sheep (Ovis ovis) and red deer (Cervus elaphus). AM Simpson, AJF Webster, JS Smith, CA Simpson | 29 | 1977 |
Reversal of the effects of xylazine and xylazine/ketamine in red deer. WAC McKelvey, CA Simpson | 14 | 1985 |
Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana K Swope, J Morton, GP Pogue, L Burden, N Partain, S Hume, J Shepherd, ... MAbs 14 (1), 2013594, 2022 | 13 | 2022 |
Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception B Shrestha, K Vincent, A Schaefer, Y Zhu, G Vargas, M Motamedi, ... Proceedings of the National Academy of Sciences 118 (48), e2107832118, 2021 | 10 | 2021 |
Manufacturing plant-made monoclonal antibodies for research or therapeutic applications K Swope, J Morton, GP Pogue, S Hume, MH Pauly, J Shepherd, ... Methods in Enzymology 660, 239-263, 2021 | 8 | 2021 |
Nanomed.: Nanotechnol CA Simpson, KJ Salleng, DE Cliffel, DL Feldheim Biol. Med 9, 257-263, 2013 | 8* | 2013 |
In vivo testing for gold nanoparticle toxicity CA Simpson, BJ Huffman, DE Cliffel NanoBiotechnology Protocols, 175-186, 2013 | 6 | 2013 |
CoV-RBD121-NP vaccine candidate protects against symptomatic disease following SARS-CoV-2 challenge in K18-hACE2 mice and induces protective responses that prevent COVID-19 … JK DeMarco, JM Royal, WE Severson, JD Gabbard, S Hume, J Morton, ... Vaccines 9 (11), 1346, 2021 | 4 | 2021 |
J. Salleng K, DE Cliffel, and DL Feldheim,“ CA Simpson vivo toxicity, biodistribution, and clearance of glutathionecoated gold …, 2013 | 4 | 2013 |
Virus and antigen purification and conjugation L Burden, SD Hume, J Morton, G Pogue, B Bratcher, HA Haydon, ... US Patent 11,529,413, 2022 | 2 | 2022 |